Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...
Regarding the industry's talent pipeline, Dr. de Miguel highlights the importance of education programs in the fields of science, technology, engineering, and mathematics (STEM) in building the ...
According to Priovant, the Phase 2 BEACON study is the first industry-sponsored placebo-controlled trial in cutaneous sarcoidosis to deliver positive data.
Clinical Trials Arena on MSN
Lundbeck’s migraine prevention drug meets primary endpoint in Phase IIb trial
Lundbeck will advance the IV formulation of the drug to Phase III trials after the successful Phase IIb trial.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results